Intensive glucose control and macrovascular outcomes in type 2 diabetes.

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

AIMS/HYPOTHESIS: Improved glucose control in type 2 diabetes is known to reduce the risk of microvascular events. There is, however, continuing uncertainty about its impact on macrovascular disease. The aim of these analyses was to generate more precise estimates of the effects of more-intensive, c...

Полное описание

Библиографические подробности
Главные авторы:	Turnbull, F, Abraira, C, Anderson, R, Byington, R, Chalmers, J, Duckworth, W, Evans, G, Gerstein, H, Holman, R, Moritz, T, Neal, B, Ninomiya, T, Patel, A, Paul, S, Travert, F, Woodward, M
Формат:	Journal article
Язык:	English
Опубликовано:	2009

Схожие документы

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
по: Zoungas, S, и др.
Опубликовано: (2009)

Microvascular and macrovascular disease in subjects with increased but not diabetic fasting glucose levels
по: Karunakaran, S, и др.
Опубликовано: (1996)

The effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
по: Zoungas, S, и др.
Опубликовано: (2017)

Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes
по: Woodward, M, и др.
Опубликовано: (2016)

Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial
по: Hata, J, и др.
Опубликовано: (2012)

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial.
по: Hata, J, и др.
Опубликовано: (2013)

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
по: Patel, A, и др.
Опубликовано: (2008)

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: The advance trial
по: Hata, J, и др.
Опубликовано: (2013)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
по: Mohammedi, K, и др.
Опубликовано: (2017)

FPG and HbA(1c) are independent risk factors for microvascular but not macrovascular complications in newly diagnosed type 2 diabetes
по: Kim, J, и др.
Опубликовано: (2005)

Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78.
по: Cull, C, и др.
Опубликовано: (2007)

Envolvimento macrovascular e esclerose sistêmica Macrovascular involvement and systemic sclerosis
по: Emmanuelle Tenório Albuquerque Madruga Godoi, и др.
Опубликовано: (2009-03-01)

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
по: Stratton, I, и др.
Опубликовано: (2000)

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.
по: Stettler, C, и др.
Опубликовано: (2006)

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis
по: Lv, J, и др.
Опубликовано: (2012)

Mean platelet volume (MPV) as new marker of diabetic macrovascular complications in patients with different glucose homeostasis
по: Velia Cassano, и др.
Опубликовано: (2024-03-01)

Micro- and Macrovascular Complications in Diabetes Mellitus: Preclinical and Clinical Studies
по: Érika B. Rangel, и др.
Опубликовано: (2019-01-01)

Follow-up of Intensive Glucose Control in Type 2 Diabetes Reply
по: Holman, R, и др.
Опубликовано: (2009)

Healthy lifestyle factors and combined macrovascular and microvascular events in diabetes patients with high cardiovascular risk: results from ADVANCE
по: Shoujiang You, и др.
Опубликовано: (2025-02-01)

Type 2 Diabetes Mellitus and Macrovascular Complications
по: Peng-Fei Shan, и др.
Опубликовано: (2017-01-01)

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.
по: Adler, A, и др.
Опубликовано: (2000)

Exploring Mechanisms of Diabetes-Related Macrovascular Complications: Role of Methylglyoxal, a Metabolite of Glucose on Regulation of Vascular Contractility
по: Masashi Mukohda, и др.
Опубликовано: (2012-01-01)

Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials.
по: Turnbull, F, и др.
Опубликовано: (2008)

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
по: Welsh, P, и др.
Опубликовано: (2018)

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
по: Patel, A, и др.
Опубликовано: (2007)

Molecular Mechanisms of Methylglyoxal in Diabetes-related Macrovascular Complications
по: Anna Meiliana, и др.
Опубликовано: (2024-10-01)

Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?
по: Aastha Chawla, и др.
Опубликовано: (2016-01-01)

10-year follow-up of intensive glucose control in type 2 diabetes.
по: Holman, R, и др.
Опубликовано: (2008)

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis.
по: Jicheng Lv, и др.
Опубликовано: (2012-01-01)

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
по: Zoungas, S, и др.
Опубликовано: (2012)

Diabetic microvascular complications: possible targets for improved macrovascular outcomes
по: Bijan Roshan, и др.
Опубликовано: (2010-12-01)

Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
по: Jung Hee Kim, и др.
Опубликовано: (2011-12-01)

Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes
по: L. Tang, и др.
Опубликовано: (2017-08-01)

Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications
по: Bao Sun, и др.
Опубликовано: (2021-01-01)

HIV‐Associated Cardiovascular Disease: Beyond the Macrovascular
по: Ashley B. Pournamdari, и др.
Опубликовано: (2023-11-01)

Symposium 13: Impact of prediabetes on macrovascular disease
по: Carolina Gómez Martin
Опубликовано: (2022-09-01)

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
по: Perkovic, V, и др.
Опубликовано: (2013)

Supramaximal vs functional high-intensity interval training effects on macrovascular reactivity in young male athletes
по: Witid Mitranun
Опубликовано: (2018-06-01)

Association between diabetic nephropathy and other diabetic microvascular and macrovascular complications
по: Chandy Anila, и др.
Опубликовано: (2008-01-01)

Estimating individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
по: Woodward, M, и др.
Опубликовано: (2016)